Novel multicellular organotypic models of normal and malignant breast: Tools for dissecting the role of the microenvironment in breast cancer progression

Breast Cancer Research

Volumn 11, Issue 1, 2009, Pages

  Holliday, Deborah L ^a   Brouilette, Kellie T ^b   Markert, Anja ^a   Gordon, Linda A ^a   Jones, J Louise ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; MATRIX METALLOPROTEINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURGERY; CELL DIFFERENTIATION; CELL DISRUPTION; CELL IMMORTALIZATION; CELL POLARITY; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VIVO STUDY; INTRADUCTAL CARCINOMA; LIVER CELL; MICROENVIRONMENT; MYOEPITHELIUM CELL; POLARIZATION; TUMOR CELL; BREAST; BREAST TUMOR; CANCER INVASION; CELL CULTURE; COCULTURE; CYTOLOGY; DISEASE COURSE; DRUG ANTAGONISM; EPITHELIUM CELL; METABOLISM; PATHOLOGY; PHENOTYPE; STROMA CELL;

BREAST; BREAST NEOPLASMS; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MET; STROMAL CELLS;

EID: 67549107230     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2218     Document Type: Article

References (32)

1. Holliday DL, Hughes S, Shaw JA, Walker RA, Jones JL. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res 2007, 9:R67. 2242664, 17922906, 10.1186/bcr1775.
2. Parr C, Jiang WG. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer 2006, 119:1176-1183. 10.1002/ijc.21881, 16557597.
3. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348. 10.1016/j.cell.2005.02.034, 15882617.
4. Nielsen BS, Rank F, Illemann M, Lund LR, Dano K. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor. Int J Cancer 2007, 120:2086-2095. 10.1002/ijc.22340, 17290405.
5. Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, Hirtenlehner K, Seifert M, Kubista E. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat 2002, 72:69-77. 10.1023/A:1014918512569, 12000221.
6. Adams M, Jones JL, Walker RA, Pringle JH, SC B. Changes in Tenascin-C isoform expression in invasive and pre-invasive breast disease. Cancer Res 2002, 62:3289-3297.
7. Shao ZM, Nguyen M, Alpaugh ML, O'Connell JT, Barsky SH. The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res 1998, 241:394-403. 10.1006/excr.1998.4066, 9637781.
8. Jones JL, Shaw JA, Pringle JH, Walker RA. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol 2003, 201:562-572. 10.1002/path.1483, 14648659.
9. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32. 10.1016/j.ccr.2004.06.010, 15261139.
10. Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610. 10.1016/j.cell.2007.08.006, 17719539.
11. Streuli CH, Bailey N, Bissell MJ. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 1991, 115:1383-1395. 2289247, 1955479, 10.1083/jcb.115.5.1383.
12. Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz AP, Roskelley C, Bissell MJ. Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol 1995, 129:591-603. 2120432, 7730398, 10.1083/jcb.129.3.591.
13. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245. 2139858, 9105051, 10.1083/jcb.137.1.231.
14. Cukierman E. Cell migration analyses within fibroblast-derived 3-D matrices. Methods Mol Biol 2005, 294:79-93.
15. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003, 13:264-269. 10.1016/S0962-8924(03)00057-6, 12742170.
16. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005, 5:675-688. 10.1038/nrc1695, 16148884.
17. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
18. Nelson CM, Bissell MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 2005, 15:342-352. 10.1016/j.semcancer.2005.05.001, 15963732.
19. O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver AR, Davies DC, Alsop AE, Neville AM, Jat PS. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci USA 2001, 98:646-651. 14642, 11209060, 10.1073/pnas.98.2.646.
20. Gordon LA, Mulligan KT, Maxwell-Jones H, Adams M, Walker RA, Jones JL. Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer 2003, 106:8-16. 10.1002/ijc.11172, 12794751.
21. Gomm JJ, Coope RC, Browne PJ, Coombes RC. Separated human breast epithelial and myoepithelial cells have different growth factor requirements in vitro but can reconstitute normal breast lobuloalveolar structure. J Cell Physiol 1997, 171:11-19. 10.1002/(SICI)1097-4652(199704)171:1<11::AID-JCP2>3.0.CO;2-K, 9119887.
22. Gusterson BA, Ross DT, Heath VJ, Stein T. Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res 2005, 7:143-148. 1175069, 15987465, 10.1186/bcr1041.
23. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996, 76:69-125.
24. Pechoux C, Gudjonsson T, Ronnov-Jessen L, Bissell MJ, Petersen OW. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 1999, 206:88-99. 10.1006/dbio.1998.9133, 9918697.
25. Runswick SK, O'Hare MJ, Jones L, Streuli CH, Garrod DR. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 2001, 3:823-830. 10.1038/ncb0901-823, 11533662.
26. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 2002, 115:39-50.
27. Bergstraesser LM, Srinivasan G, Jones JC, Stahl S, Weitzman SA. Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells. Am J Pathol 1995, 147:1823-1839. 1869964, 7495306.
28. Sieuwerts AM, Klijn JG, Henzen-Logmand SC, Bouwman I, Van Roozendaal KE, Peters HA, Setyono-Han B, Foekens JA. Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells. Int J Cancer 1998, 76:829-835. 10.1002/(SICI)1097-0215(19980610)76:6<829::AID-IJC11>3.0.CO;2-Y, 9626349.
29. Beviglia L, Matsumoto K, Lin CS, Ziober BL, Kramer RH. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int J Cancer 1997, 74:301-309. 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E, 9221809.
30. Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, Dano K, Lopez-Otin C. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001, 61:7091-7100.
31. Zhao YG, Xiao AZ, Park HI, Newcomer RG, Yan M, Man YG, Heffelfinger SC, Sang QX. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res 2004, 64:590-598. 10.1158/0008-5472.CAN-03-1932, 14744773.
32. Shekhar MP, Tait L, Pauley RJ, Wu GS, Santner SJ, Nangia-Makker P, Shekhar V, Nassar H, Visscher DW, Heppner GH, Miller FR. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biol Ther 2008, 7.